OClawVPS.com
Edit

Cantos Ventures

http://www.cantos.vc
Last activity: 26.10.2025
Active
Invests in categories: TechnologyHealthTechPlatformProductIndustryDataChemicalsHumanSpaceChemical
Portfolio
56
Persons
5
Mentions
22
Investment Type: Venture Capital

Portfolio 56

DateNameWebsiteTotal RaisedLocation
19.09.2025MoldComoldco.com$11MUnited Sta...
01.06.2023Modulo Biomodulo.bio$13.3MUnited Sta...
03.01.2023Dusty Robo...dustyrobotics.com$111.5MUnited Sta...
05.05.2022mako-aerospace.com$700KUnited Kin...
22.07.2021Faeth Ther...faeththerapeutics.com$92MUnited Sta...
22.07.2021Glyphic Bi...glyphic.bio$6MUnited Sta...
22.07.2021Twelvetwelve.co$832MUnited Sta...
22.07.2021Tiamat Sci...tiamat-sciences.com$5MUnited Sta...
22.07.2021Sixfold Bi...sixfold.bio$10.5MUnited Kin...
22.07.2021Atomos Spa...atomosspace.com$21.2MUnited Sta...
Show more

Persons 5

DateFirst NameLast NameTitleLinkedInLocation
-NatalieVolpeVenture Pa...linkedin.c...-
-HaNguyenCFOlinkedin.c...-
-AngelicaMason-linkedin.c...-
-IanRountreeFounder &a...linkedin.c...-
-AmeeKapadiaPrincipallinkedin.c...-

Mentions in press and media 22

DateTitleDescription
26.10.2025Adaptyx Biosciences: $14 Million Raised To Advance Multi-Analyte Wearable PlatformAdaptyx Biosciences has raised $14 million in seed financing to advance the development of its multi-analyte biowearable platform, bringing total funding to $23 million. Interlagos led the Menlo Park-based startup’s round with participation...
21.10.2025Faeth Therapeutics Secures $25M to Propel Cancer Metabolism TherapiesFaeth Therapeutics secured $25 million, raising its total capital to $92 million. This vital funding drives its lead PIKTOR program for endometrial cancer into Phase 2, following an impressive 80% response rate. It also expands the AI-drive...
21.10.2025Faeth Therapeutics Raises $25M in FundingCredit: Faeth Therapeutics Faeth Therapeutics, an Austin, Texas-based clinical-stage biotechnology company advancing therapies that systematically target tumor metabolism, raised $25m in funding. The financing, which brought total capital r...
20.10.2025Adaptyx Raises $14M in Seed FinancingAdaptyx Biosciences, a Menlo Park, CA-based biowearables company developing a platform for continuous, multi-analyte molecular monitoring, raised $14m in seed financing, bringing total funding to $23m since inception. The round was led by I...
20.10.2025Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial CancerFaeth Therapeutics, a clinical-stage biotechnology company pioneering metabolism-based cancer therapies, announced a $25 million strategic financing round to advance its lead program, PIKTOR, in endometrial cancer. The raise brings Faeth’s ...
22.09.2025MoldCo Fights Invisible Health Crisis with $8M Funding BoostMoldCo recently secured $8M in seed funding, bringing its total to $11M. This investment targets America's silent mold toxicity epidemic. MoldCo's telehealth platform delivers affordable, expert-led diagnosis and evidence-based treatment fo...
22.09.2025MoldCo: $8 Million Closed To Make Mold Detoxification Part Of Preventive HealthcareMoldCo is a digital health platform led by clinicians that aims to make mold detoxification a standard part of preventive healthcare. Recently, the company announced it has successfully secured $8 million in seed funding, co-led by Cantos a...
19.09.2025MoldCo Raises $8M to Combat the “Invisible Health Crisis” of Mold ToxicityWhat You Should Know: – MoldCo, a telehealth platform specializing in the diagnosis and treatment of mold and environmental toxins, has announced it has raised $8M in seed funding co-led by Cantos and Collaborative Fund. The funding brings ...
18.09.2025MoldCo Raises $8M in Seed FundingMoldCo, a Boston, MA-based provider of a clinician-led digital health platform standardizing mold detox as routine preventative care, raised $8M in Seed funding. The round was led by Cantos and Collaborative Fund. The company intends to use...
30.05.2023London-based Talis Capital announces first closing of €164 million Talis Ventures III, firm’s largest fund to date-
Show more

Reviews 0

Sign up to leave a review

Sign up Log In